Culturelle Digestive Daily is a general digestive probiotic. It appears in this review because its current US capsule panel makes a useful contrast with products carrying GLP-1 wording: it prints a recognizable strain designation and two different forms of quantity information. That comparison does not change how the product is marketed or what it has been shown to do.
The selected record is the thirty-capsule US product, including its current official Supplement Facts artwork and public variant data. The broader comparison explains the editorial selection. No personal trial, delivered-package inspection or recommendation for a prescription user is claimed here.
Keep this distinction in view
An identifiable GG strain is useful evidence detail, but does not establish a clinical role for every person taking a GLP-1 medicine.
Define the selection before using the brand name
The current manufacturer page offers thirty- and fifty-capsule choices under Digestive Daily. This review follows the thirty-capsule variant, SKU 049100400099, rather than borrowing a price from one selection and a quantity from another. Other Culturelle products, including blends and different formats, are outside this record. Two official facts images were inspected and agreed on the ingredient declarations discussed below. That is evidence of the published artwork, not a test of a household package. The finished-formula guide uses the distinction between a brand, a retail preparation and a research preparation to keep comparisons specific.
GG belongs with the organism name
The inspected panel identifies Lactobacillus rhamnosus GG. NIH’s terminology table uses Lacticaseibacillus as the updated genus and notes the former Lactobacillus name. A review can preserve the words printed on the panel while explaining that nomenclature context; it should not silently replace the label with a reconstructed one. The strain-name guide shows why the GG designation matters beyond the genus and species. However, recognition of a strain does not establish that every outcome reported for it applies to every preparation, population or purpose. An exact citation still needs its own methods and clinical context. NIH nomenclature and evidence
Read both quantities without creating a ratio
The facts images print 40 mg and 10 billion CFUs beside the named organism, with a one-capsule serving. They also declare chicory-root-extract inulin 200 mg. Those paired quantities describe this product record; they do not provide a universal mass-to-CFU conversion that can be applied to CoreAge’s blend weight. The measurement guide explains that a label’s unit, organism scope and time point have to remain attached to the number. Counting the visible digits is not a way to compare potency across unrelated preparations. The printed serving is retained as documentation, without becoming a personal intake instruction.
The rest of the capsule remains part of the record
Other ingredients on the pictured declaration include hydroxypropyl methylcellulose, vegetable magnesium stearate and titanium dioxide for color. A review focused only on GG would leave that finished-product information out. The manufacturer also describes individually sealed packaging and guarantees the labeled potency through the date on the box when stored as directed. Those are product statements with conditions; this publication did not measure a delivered lot or evaluate its storage history. The Pendulum review concerns a different blend and a different printed counting unit. Similar capsule formats cannot remove differences in formulation or establish identical handling needs.
Research about a strain is not a universal indication
NIH’s probiotic review describes evidence that varies by condition and strain, including mixed findings in particular clinical settings. Its discussion does not turn this digestive supplement into a GLP-1-branded treatment. Our trial and survey guide therefore asks whether the study population, preparation and endpoint match the claim being considered. A company’s long research history or a familiar strain name cannot answer that question alone. NCCIH also emphasizes remaining uncertainties about usefulness and safety. These sources do not authorize this publication to decide compatibility with medicines, suitability during serious illness or a schedule for an individual. NCCIH
The selected order has its own price and renewal
The current public variant response lists the thirty-capsule selection at $17.99 for a one-time purchase. Its recurring allocations are $16.19 per order, with thirty- or sixty-day delivery choices. The separate subscription page advertises ten percent savings, free subscription shipping without a minimum and the ability to skip or cancel through its management arrangements. The site separately advertises free shipping on orders over $40, which does not make a lone $17.99 one-time selection an all-in delivered quote. No account, order change or cancellation was tested. Delivery frequency is a seller choice, not a clinical recommendation about duration or use.
A refund request and a care question have different destinations
The official refund page states that direct Culturelle.com purchases can be considered for a refund excluding applicable shipping, or replacement, within thirty days of receipt. It may request a return and reserves approval; other retailers have their own policies. Direct fetch attempts did not recover that page, so this statement is based on the official page available through the web index, with that access limit recorded. No refund outcome is promised. Customer-service availability concerns a commercial enquiry; it does not establish access to a clinician, a response deadline for symptoms or a coordinated medication review. The fixed reader asks which document can answer which question. The manufacturer handles its formula and transaction records; a qualified care professional handles the relevance to an actual health concern. FDA’s general supplement information supplies no individual clearance. FDA
Sources for this article
Culturelle: US Digestive Daily Probiotic Capsules
Fresh exact US product page plus two inspected official facts images; general digestive product, not GLP-1-specific branding or universal clinical indication
Checked 2026-09-28
https://culturelle.com/products/digestive-daily-probioticNIH Office of Dietary Supplements: Probiotics, Health Professional Fact Sheet
Federal evidence review for organism nomenclature, strain-specific clinical context, mechanisms and quantities; no product or patient clearance
Checked 2026-09-28
https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/NCCIH: Probiotics, Usefulness and Safety
Federal evidence and safety uncertainties; professional-care boundary, no personal regimen or delay of clinical care
Checked 2026-09-28
https://www.nccih.nih.gov/health/probiotics-usefulness-and-safetyCulturelle: public Digestive Daily variant and selling-plan record
Fresh public structured response; selected US thirty-capsule variant 39930481082446 and its recurring allocations, no checkout verification
Checked 2026-09-28
https://culturelle.com/products/digestive-daily-probiotic.jsCulturelle: Subscribe & Save
Fresh direct public HTML visible text; recurring shipping and management claims, not tested cancellation or delivered-date guarantee
Checked 2026-09-28
https://culturelle.com/pages/subscribeCulturelle: Refund and Return Policy
Official-page web-index fallback retrieved September 28, 2026 and reported crawled two weeks earlier after direct/TinyFish failures; direct-purchase eligibility, shipping exclusion and reserved approval, no tested refund
Checked 2026-09-28
https://culturelle.com/pages/refund-and-return-policyFDA: Information for Consumers on Using Dietary Supplements
Primary regulator supplement overview; no product approval, legal compliance verdict or individual eligibility
Checked 2026-09-28
https://www.fda.gov/food/dietary-supplements/information-consumers-using-dietary-supplements